Aeterna Zentaris to Present at Upcoming Bio CEO & Investor Conference in New York

QUÉBEC CITY, Feb. 8 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS, TSX: AEZ) today announced that its President and CEO, Juergen Engel, Ph.D., will make a corporate presentation at the upcoming Bio CEO & Investor Conference on Tuesday, February 15, 2011, at 1 p.m. (eastern) in the Basildon Room of the Waldorf Astoria Hotel in New York City.

A live webcast of the presentation will be available on Aeterna Zentaris' website at, in the Newsroom section. A replay of the webcast will also be available on the Company's website for a period of 90 days.

About Aeterna Zentaris Inc.

Aeterna Zentaris is a late-stage oncology drug development company currently investigating potential treatments for various cancers including colorectal, ovarian, endometrial cancer and multiple myeloma. The Company's innovative approach of "personalized medicine" means tailoring treatments to a patient's specific condition and to unmet medical needs. Aeterna Zentaris' deep pipeline is drawn from its proprietary discovery unit providing the Company with constant and long-term access to state-of-the-art therapeutic options. For more information please visit